BTL Biotechno Labs Pvt. Ltd. – An Authorised Distributor of Runtogen in India
BTL Biotechno Labs Pvt. Ltd. – An Authorised Distributor of Runtogen in India
The rapid development of cell biology, cancer research, gene editing, immunotherapy, and drug discovery has created an increasing demand for well-characterized, reproducible, and research-ready cell models. Researchers need reliable biological systems that can support functional studies, target validation, screening, disease modelling, and preclinical research.
To support these requirements in India, BTL Biotechno Labs Pvt. Ltd. is an authorised distributor of Runtogen, providing access to Runtogen's portfolio of research-grade cell products and gene-editing solutions.
About Runtogen
Runtogen is a life-science company focused on cell biology, engineered cell models, genome engineering, and research-grade biological products. Its portfolio includes tumor cell lines, primary cells, engineered stable cell lines, CRISPR-based models, and other research products designed to support biomedical and translational research.
The company's product portfolio is particularly relevant to researchers working in oncology, immunology, regenerative medicine, functional genomics, drug discovery, and therapeutic development.
Runtogen Products Available in India
Runtogen offers a broad range of cell products and research models, including:
1. Primary Cells
Runtogen provides human and animal primary cells isolated from different tissues. These models can be useful when physiologically relevant cellular systems are required for research.
The portfolio includes:
- Human primary cells
- Animal primary cells
- Mouse primary cells
- Rat primary cells
- Bovine primary cells
- Porcine primary cells
- Rabbit primary cells
- Dog primary cells
- Endothelial cells
- Fibroblasts
- Smooth muscle cells
- Stem cells
2. Tumor Cell Lines
Tumor cell lines are essential tools for cancer biology, drug screening, target validation, and therapeutic research.
Runtogen provides more than 2,000 human and animal tumor cell lines, including characterized models with relevant mutational information.
These cell models can support research involving:
- Cancer biology
- Anticancer drug screening
- Molecular pathway studies
- Target validation
- Immuno-oncology
- Preclinical research
3. CRISPR Cell Lines
CRISPR-engineered cell models enable researchers to investigate gene function and disease mechanisms by introducing targeted genetic modifications.
Runtogen offers a large portfolio of CRISPR cell lines, including knockout and knock-in models, as well as Cas9 stable cell lines. The company states that its knockout cell bank covers more than 10,000 genes, with thousands of pre-made knockout cell lines available.
These models can be valuable for:
- Functional genomics
- Gene-function studies
- Target validation
- Disease modelling
- Drug discovery
- Mechanistic research
4. Engineered Stable Cell Lines
Runtogen also provides engineered cellular models designed for specific research applications. These include:
- Overexpression stable cell lines
- Reporter cell lines
- Luciferase cell lines
- Kinase cell lines
- Immune molecule and tumor antigen cell lines
- EGFP stable cell lines
The engineered models can help researchers establish consistent experimental systems for target validation, functional assays, screening, and therapeutic research.
Immune Molecule & Tumor Antigen Cell Lines
An important area within Runtogen's portfolio is its collection of cell lines expressing immune molecules and tumor-associated antigens.
The portfolio includes research targets such as PD-1, PD-L1, CTLA-4, LAG-3, TIGIT, TIM-3, CD19, BCMA, CD20, CD22, CLDN18.2, PSMA, EGFR, HER2/ERBB2, GPC3, ROR1, GPRC5D, B7-H3, B7-H4, and Siglec-15, among others.
These models can support:
- Antibody screening
- Target validation
- CAR-T/TCR-T research
- Immuno-oncology studies
- Functional assays
- Therapeutic candidate evaluation
Runtogen also provides reporter options, including fluorescent proteins and luciferase, offering flexibility for assay development and high-throughput screening.
Luciferase and Reporter Cell Lines
Reporter systems are widely used to monitor cellular signalling and biological activity.
Runtogen provides luciferase stable cell lines as well as reporter cell lines covering pathways such as NF-κB, NFAT, GPCR, and cAMP. Different reporter genes, including GFP, RFP, and luciferase, are available across the portfolio.
These models can be applied in:
- Cell-based assays
- Signalling pathway studies
- Drug screening
- Functional assays
- In-vitro research
- In-vivo bioluminescence studies
Quality and Validation
Reproducibility is a critical consideration when selecting cell-based research models. According to Runtogen, its cell products undergo quality-control procedures including STR profiling and mycoplasma testing. The company also states that its products have >95% viability at shipment.
Products are supplied with supporting documentation such as:
- Certificate of Analysis
- Cell culture protocols
- Technical support
These quality measures are intended to help researchers establish reliable and reproducible experimental workflows.
Custom Cell Line Development and Gene Editing
Beyond ready-to-use products, Runtogen provides custom cell engineering and gene-editing services. Its services include knockout, knock-in, knockdown, overexpression, and point-mutation models, supporting customized research requirements.
Runtogen also provides specialized antibody discovery services using platforms such as hybridoma technology, phage display, single B-cell screening, and transgenic mouse platforms, along with antibody engineering and validation.
Runtogen Products in India through BTL Biotechno Labs Pvt. Ltd.
As an authorised distributor of Runtogen in India, BTL Biotechno Labs Pvt. Ltd. helps Indian researchers access Runtogen's cell biology and gene-editing portfolio.
BTL Biotechno Labs Pvt. Ltd. supports researchers from academic institutions, biotechnology companies, pharmaceutical organizations, and other life-science research facilities with product selection, quotation support, technical coordination, and procurement assistance.
Why Choose BTL Biotechno Labs Pvt. Ltd.?
Researchers in India can benefit from BTL Biotechno Labs Pvt. Ltd.'s:
- Product sourcing and quotation assistance
- Technical coordination
- Support in selecting suitable cell models
- Reliable supply coordination
- Access to Runtogen's extensive research portfolio
- Support for customized research requirements
By combining Runtogen's cell biology expertise with BTL Biotechno Labs Pvt. Ltd.'s local market support, researchers can streamline access to specialized cell lines, primary cells, CRISPR models, engineered cell lines, reporter systems, and other research products.
Runtogen's extensive portfolio of primary cells, tumor cell lines, CRISPR cell lines, engineered stable cell lines, reporter systems, stem cells, and gene-editing solutions provides researchers with versatile tools for modern life-science research.
Whether your project involves cancer research, immuno-oncology, functional genomics, drug discovery, regenerative medicine, cell-based assays, or gene editing, Runtogen's portfolio offers a broad selection of research models to support your scientific work.
For Runtogen products in India, contact BTL Biotechno Labs Pvt. Ltd. for product information, quotations, and technical assistance.
For product details, please connect with us at info@biotechnolabs.com.
